Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toujeo phase 4 single-arm study in type 2 diabetes mellitus patients inadequately controlled with basal insulin
2015-002416-33Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Primary endpoint: Mean change of HbA1c. Started Dec 2015; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-002416-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002416-33.